Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Cash (2016 - 2025)

Utah Medical Products has reported Change in Cash over the past 16 years, most recently at $1.5 million for Q4 2025.

  • Quarterly results put Change in Cash at $1.5 million for Q4 2025, up 127.19% from a year ago — trailing twelve months through Dec 2025 was $2.8 million (up 128.1% YoY), and the annual figure for FY2025 was $2.8 million, up 128.1%.
  • Change in Cash for Q4 2025 was $1.5 million at Utah Medical Products, down from $2.1 million in the prior quarter.
  • Over the last five years, Change in Cash for UTMD hit a ceiling of $5.9 million in Q1 2023 and a floor of -$5.5 million in Q4 2024.
  • Median Change in Cash over the past 5 years was $2.7 million (2022), compared with a mean of $1.7 million.
  • Biggest five-year swings in Change in Cash: surged 956.13% in 2023 and later plummeted 223.79% in 2024.
  • Utah Medical Products' Change in Cash stood at -$3.3 million in 2021, then skyrocketed by 265.55% to $5.5 million in 2022, then decreased by 15.92% to $4.7 million in 2023, then tumbled by 217.54% to -$5.5 million in 2024, then skyrocketed by 127.19% to $1.5 million in 2025.
  • The last three reported values for Change in Cash were $1.5 million (Q4 2025), $2.1 million (Q3 2025), and -$1.1 million (Q2 2025) per Business Quant data.